Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...